Financial Assets and Financial Liabilities - Narrative (Details) - EUR (€) € in Millions |
12 Months Ended | |||
|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
Apr. 30, 2025 |
|
| Disclosure of financial assets [line items] | ||||
| Financial assets pledged as collateral for liabilities or contingent liabilities | € 113.9 | |||
| Investments in equity instruments designated at fair value through other comprehensive income | 82.8 | € 94.2 | ||
| Net gain / (loss) on equity instruments designated at fair value through other comprehensive income | (15.9) | (146.6) | € 3.7 | |
| Investment in DualityBio | Equity investments | ||||
| Disclosure of financial assets [line items] | ||||
| Investments in equity instruments designated at fair value through other comprehensive income | € 13.4 | € 0.0 | € 4.5 | |
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The amount of investments in equity instruments that the entity has designated at fair value through other comprehensive income. [Refer: At fair value [member]; Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of financial assets that the entity has pledged as collateral for liabilities or contingent liabilities, including amounts that have been reclassified in accordance with paragraph 3.2.23(a) of IFRS 9. [Refer: Classes of contingent liabilities [domain]; Financial assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of other comprehensive income, net of tax, related to gains (losses) from changes in the fair value of investments in equity instruments that the entity has designated at fair value through other comprehensive income applying paragraph 5.7.5 of IFRS 9. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|